CXCR4 and neoplasm: Peptide R impaired the metabolic activity and cell proliferation of the U87 cell line, reducing CXCR4 expression and cell migration in vitro while decreasing tumor cellularity and modulating M1 features in the orthotopic in vivo model [138].